Ruben Antony, M.R.C.P., M.D.

Ruben Antony, M.R.C.P., M.D.

Specialties

Pediatric Hematology/Oncology

Pediatric Neuro-Oncology

Department

Pediatrics

Title

  • Clinical Associate Professor

Reviews

To see if Ruben Antony is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Comprehensive Cancer Center

4501 X Street, 2nd Floor
Sacramento, CA 95817
Driving Directions

Primary Phone:
800-362-5566
916-734-5959

Additional Phone Numbers

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Philosophy of Care

In the last decade we have gained many new and exciting insights into the mechanistic basis of childhood CNS malignancies. Everyday I aim to provide compassionate and cutting edge care to the children and families who have placed their trust in us. 

Clinical Interests

Dr. Antony's clinical interests are in Pediatric Neuro-Oncology.

Division

Pediatric Hematology/Oncology

Center/Program Affiliation

UC Davis Children's Hospital

Education

MBBS, St. Johns Medical College, Bangalore, India 1996

MRCP, Royal College of Physicians, UK 2001

Internship: Pediatrics, New York Medical College, New York NY 2006-2007

Residency

Pediatrics, New York Medical College, New York NY 2007-2008

Fellowships

Pediatric Hematology and Oncology, Children's Hospital of Los Angeles, Los Angeles CA 2008-2011

Pediatric Hematology and Oncology, Hospital for Sick Children, Toronto, Ontario, Canada 2005-2006

Board Certifications

American Board of Pediatrics, 2010

American Board of Pediatrics, Pediatric Hematology-Oncology, 2013

Royal College of Physicians (UK) - Pediatrics, 2000

Professional Memberships

American Society of Pediatric Hematology/Oncology

Children´┐Żs Oncology Group

Children's Cancer and Leukemia Group (UK)

Royal College of Physicians (UK)

Society of Neuro-Oncology

Select Recent Publications

Kramer M, Antony R, Ozturk A, Lehn K, Graff JP, Chung JH. A Palpable Back Mass as First Presenting Sign of Acute Lymphoblastic Leukemia in a Pediatric Patient. J Pediatr Hematol Oncol. 2019 Jan;41(1):77-78. 

Fernández KS, Antony R, Kumar A. Patients with "ALPS-like phenotype" diagnosed with immune dysregulation due to LRBA deficiency. Pediatr Blood Cancer. 2019 Mar;66(3):e27558. 

McCarthy LC, Fernandez KS, Antony R. Challenges in the Diagnosis and Management of Pediatric Hemophagocytic Lymphohistiocytosis. Clin Pediatr (Phila). 2018 Aug;57(9):1107-1113. 

Gnanamony M, Antony R, Fernández KS, Jaime L, Lin J, Joseph PA, Gondi CS. Chronic radiation exposure of neuroblastoma cells reduces nMYC copy number. Oncol Lett. 2017 Sep;14(3):3363-3370.

Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y, Beckett L, Chung J, Antony R, Nolta J, Nitin N, Satake N. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA. Pediatr Res. 2017 Sep;82(3):527-535

Tanpure S, Boyineini J, Gnanamony M, Antony R, Fernández KS, Libes J, Lin J, Pinson D, Joseph PA, Gondi CS. SPARC overexpression suppresses radiation-induced HSP27 and induces the collapse of mitochondrial Δψ in neuroblastoma cells. Oncol Lett. 2017 Jun;13(6):4602-4610

S. Tanpure, J. Boyineini, M. Gnanamony R. Antony, K.S. Fernández, J. Libes, J. Lin, D. Pinson and C.S. Gondi SPARC overexpression retards radiation induced HSP27 and induces the collapse of mitochondrial ψ in neuroblastoma cells: Accepted for publication Oncology Letters 2016 Nov 30th.

Boyineni J, Tanpure S, Gnanamony M, Antony R, Fernández KS, Lin J, Pinson D, Gondi CS.SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR 410 in human neuroblastoma cells. Int J Oncol. 2016 Oct;49(4):1394-406. 

 

Asuthkar S, Guda MR, Martin SE, Antony R, Fernandez K, Lin J, Tsung AJ, Velpula KK. Hand1 overexpression inhibits medulloblastoma metastasis. Biochem Biophys Res Commun. 2016 Aug 19;477(2):215-21. 

 

Jerusha Boyineni, Smita Tanpure, Manu Gnanamony1, Reuben Antony, Karen S. Fernández, Julian Lin3, David Pinson, and Christopher S. Gondi SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR410 in human neuroblastoma cells. Int. Journal of Oncology , 2016 August 3rd(Epub).